AP2964A - Powders for reconstitution - Google Patents
Powders for reconstitutionInfo
- Publication number
- AP2964A AP2964A AP2009004969A AP2009004969A AP2964A AP 2964 A AP2964 A AP 2964A AP 2009004969 A AP2009004969 A AP 2009004969A AP 2009004969 A AP2009004969 A AP 2009004969A AP 2964 A AP2964 A AP 2964A
- Authority
- AP
- ARIPO
- Prior art keywords
- reconstitution
- powders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Inorganic Chemistry (AREA)
- AIDS & HIV (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07104082 | 2007-03-14 | ||
PCT/EP2008/053056 WO2008110619A1 (en) | 2007-03-14 | 2008-03-14 | Powders for reconstitution |
Publications (2)
Publication Number | Publication Date |
---|---|
AP2009004969A0 AP2009004969A0 (en) | 2009-10-31 |
AP2964A true AP2964A (en) | 2014-09-30 |
Family
ID=38055251
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AP2009004969A AP2964A (en) | 2007-03-14 | 2008-03-14 | Powders for reconstitution |
Country Status (18)
Country | Link |
---|---|
US (1) | US8916558B2 (xx) |
EP (1) | EP2043608B1 (xx) |
JP (1) | JP5554571B2 (xx) |
KR (1) | KR101580297B1 (xx) |
CN (1) | CN101636149B (xx) |
AP (1) | AP2964A (xx) |
AR (2) | AR065720A1 (xx) |
AU (1) | AU2008225774B2 (xx) |
BR (1) | BRPI0808897B8 (xx) |
CA (1) | CA2676981C (xx) |
CL (1) | CL2008000746A1 (xx) |
ES (1) | ES2535162T3 (xx) |
IL (1) | IL199874A (xx) |
MX (1) | MX2009009743A (xx) |
RU (1) | RU2477133C2 (xx) |
TW (1) | TWI494133B (xx) |
WO (1) | WO2008110619A1 (xx) |
ZA (1) | ZA200906344B (xx) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY169670A (en) | 2003-09-03 | 2019-05-08 | Tibotec Pharm Ltd | Combinations of a pyrimidine containing nnrti with rt inhibitors |
TWI494133B (zh) | 2007-03-14 | 2015-08-01 | Tibotec Pharm Ltd | 重組用粉末 |
CN108210469A (zh) | 2011-04-15 | 2018-06-29 | 詹森药业有限公司 | 冻干药物纳米混悬剂 |
JP6301339B2 (ja) * | 2012-09-27 | 2018-03-28 | ビーエーエスエフ ソシエタス・ヨーロピアBasf Se | 少なくとも1種の水溶性ビタミンe誘導体および少なくとも1種の親水性ポリマーを含む、保存において安定な無塵の均質な粒子製剤 |
EP3993799A1 (en) * | 2019-07-03 | 2022-05-11 | Janssen Sciences Ireland Unlimited Company | Methods of treating hiv in pediatric patients with rilpivirine |
CN113440529B (zh) * | 2020-03-25 | 2023-11-14 | 江苏恒瑞医药股份有限公司 | 一种可注射的药物组合物及其制备方法 |
CN114392241B (zh) * | 2022-01-10 | 2023-07-25 | 安徽贝克生物制药有限公司 | 一种利匹韦林片及其制备方法 |
TW202406551A (zh) * | 2022-04-22 | 2024-02-16 | 愛爾蘭商健生科學愛爾蘭無限公司 | 冷凍乾燥組成物(一) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0489181A1 (en) * | 1990-07-19 | 1992-06-10 | Otsuka Pharmaceutical Co., Ltd. | Solid preparation |
US5368864A (en) * | 1988-11-25 | 1994-11-29 | Henning Berlin Gmbh Chemie- Und Pharmawerk | Formulation of oxypurinol and/or its alkali and alkaline earth salts |
WO2004050058A2 (en) * | 2002-11-29 | 2004-06-17 | Janssen Pharmaceutica N.V. | Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base |
WO2006108828A1 (en) * | 2005-04-11 | 2006-10-19 | Tibotec Pharmaceuticals Ltd. | (1, 10b-dihydro-2-(aminoalkyl- phenyl)-5h-pyraz0l0 [1,5-c] [1,3] benz0xazin-5-yl) phenyl methanone derivatives as hiv viral repliation inhibitors |
Family Cites Families (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3089818A (en) * | 1960-06-02 | 1963-05-14 | Baxter Laboratories Inc | Water dispersible antibiotics |
US5182111A (en) * | 1987-11-17 | 1993-01-26 | Boston University Research Foundation | In vivo delivery of active factors by co-cultured cell implants |
US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
CA2121129A1 (en) * | 1991-10-29 | 1993-05-13 | Patrick Soon-Shiong | Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release |
AU4079593A (en) | 1992-05-13 | 1993-12-13 | Wellcome Foundation Limited, The | Therapeutic combinations |
JPH06316524A (ja) | 1992-09-11 | 1994-11-15 | Naoyuki Inoue | 抗エイズウイルス剤 |
TW401303B (en) | 1994-07-01 | 2000-08-11 | Janssen Pharmaceutica Nv | Anti-HIV triple combination |
US6045829A (en) * | 1997-02-13 | 2000-04-04 | Elan Pharma International Limited | Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers |
CA2383233C (en) | 1999-09-21 | 2010-06-08 | Rtp Pharma Inc. | Surface modified particulate compositions of biologically active substances |
CZ300712B6 (cs) * | 1999-09-24 | 2009-07-22 | Janssen Pharmaceutica N. V. | Cásticová farmaceutická kompozice, pevná disperze a farmaceutická dávková forma, zpusoby jejich prípravy a použití a obchodní balení s jejich obsahem |
US6743446B2 (en) * | 1999-12-15 | 2004-06-01 | The Ohio State University Research Foundation | Methods for stabilizing biologically active agents encapsulated in biodegradable controlled-release polymers |
TWI284048B (en) * | 2000-01-27 | 2007-07-21 | Zentaris Ag | Compressed microparticles for dry injection |
RU2239435C2 (ru) | 2000-03-30 | 2004-11-10 | Бристол-Маерс Сквибб Компани | Гранулы пролонгированного высвобождения, содержащие ставудин |
US20040115268A1 (en) * | 2000-04-26 | 2004-06-17 | Control Delivery Systems, Inc. | Systemic delivery of antiviral agents |
DE10050199A1 (de) | 2000-10-11 | 2002-04-25 | Ethicon Gmbh | Flächiges Implantat mit im Ultraschall detektierbaren Elementen |
AU2002221096A1 (en) | 2000-12-11 | 2002-06-24 | Takeda Chemical Industries Ltd. | Medicinal compositions improved in solublity in water |
BR0210518A (pt) | 2001-06-22 | 2004-06-22 | Pfizer Prod Inc | Composições farmacêuticas de dispersões de drogas e polìmeros neutros |
JO3429B1 (ar) * | 2001-08-13 | 2019-10-20 | Janssen Pharmaceutica Nv | مشتقات برميدينات مثبطة فيروس الايدز |
MY169670A (en) * | 2003-09-03 | 2019-05-08 | Tibotec Pharm Ltd | Combinations of a pyrimidine containing nnrti with rt inhibitors |
WO2003043586A2 (en) | 2001-11-20 | 2003-05-30 | Advanced Inhalation Research, Inc. | Compositions for sustained action product delivery |
CA2493794C (en) | 2002-08-09 | 2010-05-25 | Janssen Pharmaceutica N.V. | Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |
AU2003278766A1 (en) * | 2002-09-04 | 2004-03-29 | Microchips, Inc. | Method and device for the controlled delivery of parathyroid hormone |
US20050287177A1 (en) | 2002-11-08 | 2005-12-29 | Glaxo Group Unlimited And Smithkline Beecham Corp. | Pharmaceutical compositions |
NZ540321A (en) | 2002-11-15 | 2007-09-28 | Tibotec Pharm Ltd | Substituted indolepyridinium as anti-infective compounds |
CL2004000192A1 (es) | 2003-02-07 | 2005-03-18 | Janssen Pharmaceutica Nv | Uso de compuestos derivados de 2-aminopirimidina para preparar un medicamento para la prevencion de una infeccion por vih relaciones sexuales o un contacto intimo en la pareja. |
KR100629771B1 (ko) * | 2004-01-27 | 2006-09-28 | 씨제이 주식회사 | 결정성이 감소되거나 무정형화된 올티프라즈의 제조방법 |
CN102512372A (zh) * | 2004-06-08 | 2012-06-27 | 沃泰克斯药物股份有限公司 | 药物组合物 |
MY191349A (en) | 2004-08-27 | 2022-06-17 | Bayer Pharmaceuticals Corp | New pharmaceutical compositions for the treatment of hyper-proliferative disorders |
AU2005279158C1 (en) | 2004-09-02 | 2010-12-16 | Janssen Pharmaceutica N.V. | Hydrochloride of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl] amino]benzonitrile |
JP4912309B2 (ja) | 2004-09-02 | 2012-04-11 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 4−[[4−[[4−(2−シアノエテニル)−2,6−ジメチルフェニル]アミノ]−2−ピリミジニル]アミノ]ベンゾニトリルの塩酸塩 |
WO2006055603A2 (en) | 2004-11-16 | 2006-05-26 | Elan Pharma International Ltd. | Injectable nanoparticulate olanzapine formulations |
TW201414495A (zh) | 2005-04-04 | 2014-04-16 | Tibotec Pharm Ltd | Hiv-感染之預防 |
AU2006235565A1 (en) * | 2005-04-11 | 2006-10-19 | The Board Of Trustees Of The Leland Stanford Junior University | Multi-layer structure having a predetermined layer pattern including an agent |
US20090142401A1 (en) | 2005-06-07 | 2009-06-04 | Leah Elizabeth Appel | Multiparticulates comprising low-solubility drugs and carriers that result in rapid drug release |
CN101272769B (zh) * | 2005-07-28 | 2013-04-24 | Isp投资有限公司 | 生物利用度提高的苯醌类化合物 |
MY150717A (en) | 2006-01-20 | 2014-02-28 | Tibotec Pharm Ltd | Long term treatment of hiv-infection with tmc278 |
SI2029110T1 (sl) | 2006-06-06 | 2012-01-31 | Tibotec Pharm Ltd | Z razprševanjem posušeni pripravki TMC125 |
AR061620A1 (es) | 2006-06-23 | 2008-09-10 | Tibotec Pharm Ltd | Suspensiones acuosas de tmc278 |
US20080081064A1 (en) * | 2006-09-28 | 2008-04-03 | Surmodics, Inc. | Implantable Medical Device with Apertures for Delivery of Bioactive Agents |
TWI494133B (zh) | 2007-03-14 | 2015-08-01 | Tibotec Pharm Ltd | 重組用粉末 |
EP2175857B1 (en) | 2007-07-12 | 2013-09-11 | Janssen R&D Ireland | Crystalline form of (e) 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |
WO2009046299A2 (en) | 2007-10-04 | 2009-04-09 | Boston Scientific Scimed, Inc | Implantable drug depot for intrathecal drug delivery system for pain management |
EP2358198A4 (en) * | 2008-10-24 | 2012-11-14 | Concert Pharmaceuticals Inc | HYDROXYETHYLAMINO SULFONAMIDE DERIVATIVES |
-
2008
- 2008-03-13 TW TW097108780A patent/TWI494133B/zh active
- 2008-03-13 CL CL200800746A patent/CL2008000746A1/es unknown
- 2008-03-13 AR ARP080101032A patent/AR065720A1/es not_active Application Discontinuation
- 2008-03-14 KR KR1020097017592A patent/KR101580297B1/ko active IP Right Grant
- 2008-03-14 MX MX2009009743A patent/MX2009009743A/es active IP Right Grant
- 2008-03-14 RU RU2009137911/15A patent/RU2477133C2/ru active
- 2008-03-14 CN CN200880008342.0A patent/CN101636149B/zh active Active
- 2008-03-14 AU AU2008225774A patent/AU2008225774B2/en active Active
- 2008-03-14 JP JP2009553156A patent/JP5554571B2/ja active Active
- 2008-03-14 AP AP2009004969A patent/AP2964A/xx active
- 2008-03-14 CA CA2676981A patent/CA2676981C/en active Active
- 2008-03-14 WO PCT/EP2008/053056 patent/WO2008110619A1/en active Application Filing
- 2008-03-14 ES ES08717800.0T patent/ES2535162T3/es active Active
- 2008-03-14 US US12/530,665 patent/US8916558B2/en active Active
- 2008-03-14 EP EP08717800.0A patent/EP2043608B1/en active Active
- 2008-03-14 BR BRPI0808897A patent/BRPI0808897B8/pt active IP Right Grant
-
2009
- 2009-07-15 IL IL199874A patent/IL199874A/en active IP Right Grant
- 2009-09-11 ZA ZA2009/06344A patent/ZA200906344B/en unknown
-
2019
- 2019-01-21 AR ARP190100128A patent/AR114086A2/es not_active Application Discontinuation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5368864A (en) * | 1988-11-25 | 1994-11-29 | Henning Berlin Gmbh Chemie- Und Pharmawerk | Formulation of oxypurinol and/or its alkali and alkaline earth salts |
EP0489181A1 (en) * | 1990-07-19 | 1992-06-10 | Otsuka Pharmaceutical Co., Ltd. | Solid preparation |
WO2004050058A2 (en) * | 2002-11-29 | 2004-06-17 | Janssen Pharmaceutica N.V. | Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base |
WO2006108828A1 (en) * | 2005-04-11 | 2006-10-19 | Tibotec Pharmaceuticals Ltd. | (1, 10b-dihydro-2-(aminoalkyl- phenyl)-5h-pyraz0l0 [1,5-c] [1,3] benz0xazin-5-yl) phenyl methanone derivatives as hiv viral repliation inhibitors |
Also Published As
Publication number | Publication date |
---|---|
AP2009004969A0 (en) | 2009-10-31 |
US8916558B2 (en) | 2014-12-23 |
KR101580297B1 (ko) | 2015-12-24 |
TW200911303A (en) | 2009-03-16 |
TWI494133B (zh) | 2015-08-01 |
IL199874A (en) | 2016-02-29 |
JP5554571B2 (ja) | 2014-07-23 |
CN101636149B (zh) | 2014-08-06 |
RU2009137911A (ru) | 2011-04-20 |
AU2008225774A1 (en) | 2008-09-18 |
CA2676981C (en) | 2015-01-13 |
CL2008000746A1 (es) | 2008-09-22 |
BRPI0808897B8 (pt) | 2021-05-25 |
CN101636149A (zh) | 2010-01-27 |
ZA200906344B (en) | 2015-04-29 |
ES2535162T3 (es) | 2015-05-05 |
RU2477133C2 (ru) | 2013-03-10 |
EP2043608A1 (en) | 2009-04-08 |
US20100120795A1 (en) | 2010-05-13 |
BRPI0808897B1 (pt) | 2020-10-20 |
AR114086A2 (es) | 2020-07-22 |
AU2008225774B2 (en) | 2014-04-10 |
KR20090119964A (ko) | 2009-11-23 |
CA2676981A1 (en) | 2008-09-18 |
BRPI0808897A2 (pt) | 2014-09-02 |
AR065720A1 (es) | 2009-06-24 |
WO2008110619A1 (en) | 2008-09-18 |
MX2009009743A (es) | 2009-09-23 |
IL199874A0 (en) | 2010-04-15 |
JP2010520918A (ja) | 2010-06-17 |
EP2043608B1 (en) | 2015-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK200800103A (en) | Integreret føringskant for vindturbineblad | |
EP2209420A4 (en) | IMAGING PARTICLES | |
GB0712764D0 (en) | Carrying Bag | |
HK1143129A1 (zh) | 粉末 | |
AU319127S (en) | Container | |
AU319092S (en) | Container | |
IL190589A0 (en) | Level-restorer supply-regulated pll | |
IL199726A0 (en) | Iron-carbohydrate complex compounds | |
ZA200906344B (en) | Powders for reconstitution | |
GB0708567D0 (en) | Imaging technique | |
GB0700361D0 (en) | Pack | |
AU319091S (en) | Container | |
GB0715132D0 (en) | Tissue-adhesive materials | |
GB2455650B (en) | Vaccines for brucellosis | |
ZA200908588B (en) | Pack | |
GB0713587D0 (en) | Insulaitng materials | |
EP2130702A4 (en) | MODE OF TRANSPORT | |
GB0704646D0 (en) | Improved container | |
GB2447456B (en) | Single-shoulder bag | |
GB0707047D0 (en) | Bag | |
GB0708729D0 (en) | Booska pod bag | |
GB0725328D0 (en) | Data-handleing means | |
AU315653S (en) | Bag | |
AU315652S (en) | Bag | |
GB0719495D0 (en) | Moggy bag |